Neuralgia Treatment Market 2027 By Treatment Type, Indication, Distribution channels, Impact of covid-19 pandemic. | The Insight Partners

Neuralgia Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Treatment Type (Drug Based treatment, Surgery treatment); Indication (Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia); Distribution channels (Drug Stores, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Impact of covid-19 pandemic.

Report Code: TIPRE00015977 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Neuralgia is caused due to damage of nerves. The condition is characterized by an abnormal symptom with effects like sharp, burning, and mostly severe pain. The affected nerve may be from anywhere in the body. The nerve damage caused is associated with several factors like aging, cardiovascular diseases, diabetes, multiple sclerosis, shingles infection, and more. Neuralgia pain treatment is directed towards its roots or its site of origin. Potential Neuralgia Treatment may include surgery to relieve the pressure, control of sugar level in the blood of diabetic patients, physical therapy or body massage, epidural injections to 'turn off' pain signals and reduce inflammation. The Neuralgia Treatment market is driven by the occurrence of common neuralgias such as trigeminal, glossopharyngeal, Postherpetic, and occipital neuralgia. Serious neuralgia treatment may be required for periorbital and auricular neuralgias.

MARKET DYNAMICS

Neuralgia treatment market is driving due to factors such as increasing prevalence of diabetes and the high incidence rate of trigeminal neuralgia. Moreover, conditions such as multiple sclerosis can also cause neuralgia. Multiple sclerosis is a neurodegenerative condition, in which the body's immune system attacks the myelin sheath around neurons, causing neuralgia. However, factors such as, poor efficiency and efficacy of some drugs and high cost of surgical treatment is expected to hamper the market growth.

MARKET SCOPE

The Neuralgia treatment market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Neuralgia treatment market with detailed market segmentation by treatment type, indication and distribution channels. The Neuralgia treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Neuralgia treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Neuralgia treatment market is segmented on the basis of treatment type, indication and distribution channels. Based on treatment type, the market is segmented as Drug Based treatment, Surgery treatment. Based on indication, market is segmented as Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, and Postherpetic Neuralgia. Based on distribution channels, market is segmented as Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Neuralgia treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Neuralgia treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Neuralgia treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Neuralgia treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Neuralgia treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Neuralgia treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Neuralgia treatment in the global market. Below mentioned is the list of few companies engaged in the Neuralgia treatment market.

The report also includes the profiles of key players in Neuralgia treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Biogen Inc.,
  •  Cadila Healthcare Limited,
  •  Teva Pharmaceuticals Ltd.,
  •  GlaxoSmithKline PLC,
  •  GLENMARK PHARMS LTD.,
  •  Novartis AG,
  •  Janssen Pharmaceuticals, Inc.,
  •  Johnson & Johnson Services, Inc.,
  •  Takeda Pharmaceutical Company Limited,
  •  Pfizer Inc.,

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neuralgia Treatment Market - By Treatment Type
1.3.2 Neuralgia Treatment Market - By Indication
1.3.3 Neuralgia Treatment Market - By Distribution channels
1.3.4 Neuralgia Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEURALGIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEURALGIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEURALGIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. NEURALGIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. NEURALGIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NEURALGIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRUG BASED TREATMENT
7.3.1. Overview
7.3.2. Drug Based treatment Market Forecast and Analysis
7.4. SURGERY TREATMENT
7.4.1. Overview
7.4.2. Surgery treatment Market Forecast and Analysis
8. NEURALGIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. DIABETIC NEUROPATHY
8.3.1. Overview
8.3.2. Diabetic Neuropathy Market Forecast and Analysis
8.4. INTERCOSTAL NEURALGIA
8.4.1. Overview
8.4.2. Intercostal Neuralgia Market Forecast and Analysis
8.5. OCCIPITAL NEURALGIA
8.5.1. Overview
8.5.2. Occipital Neuralgia Market Forecast and Analysis
8.6. PERIPHERAL NEURALGIA
8.6.1. Overview
8.6.2. Peripheral Neuralgia Market Forecast and Analysis
8.7. POSTHERPETIC NEURALGIA
8.7.1. Overview
8.7.2. Postherpetic Neuralgia Market Forecast and Analysis
9. NEURALGIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNELS
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNELS MARKET FORECASTS AND ANALYSIS
9.3. DRUG STORES
9.3.1. Overview
9.3.2. Drug Stores Market Forecast and Analysis
9.4. HOSPITAL PHARMACIES
9.4.1. Overview
9.4.2. Hospital Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
9.6. RETAIL PHARMACIES
9.6.1. Overview
9.6.2. Retail Pharmacies Market Forecast and Analysis
10. NEURALGIA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Neuralgia Treatment Market Overview
10.1.2 North America Neuralgia Treatment Market Forecasts and Analysis
10.1.3 North America Neuralgia Treatment Market Forecasts and Analysis - By Treatment Type
10.1.4 North America Neuralgia Treatment Market Forecasts and Analysis - By Indication
10.1.5 North America Neuralgia Treatment Market Forecasts and Analysis - By Distribution channels
10.1.6 North America Neuralgia Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Neuralgia Treatment Market
10.1.6.1.1 United States Neuralgia Treatment Market by Treatment Type
10.1.6.1.2 United States Neuralgia Treatment Market by Indication
10.1.6.1.3 United States Neuralgia Treatment Market by Distribution channels
10.1.6.2 Canada Neuralgia Treatment Market
10.1.6.2.1 Canada Neuralgia Treatment Market by Treatment Type
10.1.6.2.2 Canada Neuralgia Treatment Market by Indication
10.1.6.2.3 Canada Neuralgia Treatment Market by Distribution channels
10.1.6.3 Mexico Neuralgia Treatment Market
10.1.6.3.1 Mexico Neuralgia Treatment Market by Treatment Type
10.1.6.3.2 Mexico Neuralgia Treatment Market by Indication
10.1.6.3.3 Mexico Neuralgia Treatment Market by Distribution channels
10.2. EUROPE
10.2.1 Europe Neuralgia Treatment Market Overview
10.2.2 Europe Neuralgia Treatment Market Forecasts and Analysis
10.2.3 Europe Neuralgia Treatment Market Forecasts and Analysis - By Treatment Type
10.2.4 Europe Neuralgia Treatment Market Forecasts and Analysis - By Indication
10.2.5 Europe Neuralgia Treatment Market Forecasts and Analysis - By Distribution channels
10.2.6 Europe Neuralgia Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Neuralgia Treatment Market
10.2.6.1.1 Germany Neuralgia Treatment Market by Treatment Type
10.2.6.1.2 Germany Neuralgia Treatment Market by Indication
10.2.6.1.3 Germany Neuralgia Treatment Market by Distribution channels
10.2.6.2 France Neuralgia Treatment Market
10.2.6.2.1 France Neuralgia Treatment Market by Treatment Type
10.2.6.2.2 France Neuralgia Treatment Market by Indication
10.2.6.2.3 France Neuralgia Treatment Market by Distribution channels
10.2.6.3 Italy Neuralgia Treatment Market
10.2.6.3.1 Italy Neuralgia Treatment Market by Treatment Type
10.2.6.3.2 Italy Neuralgia Treatment Market by Indication
10.2.6.3.3 Italy Neuralgia Treatment Market by Distribution channels
10.2.6.4 Spain Neuralgia Treatment Market
10.2.6.4.1 Spain Neuralgia Treatment Market by Treatment Type
10.2.6.4.2 Spain Neuralgia Treatment Market by Indication
10.2.6.4.3 Spain Neuralgia Treatment Market by Distribution channels
10.2.6.5 United Kingdom Neuralgia Treatment Market
10.2.6.5.1 United Kingdom Neuralgia Treatment Market by Treatment Type
10.2.6.5.2 United Kingdom Neuralgia Treatment Market by Indication
10.2.6.5.3 United Kingdom Neuralgia Treatment Market by Distribution channels
10.2.6.6 Rest of Europe Neuralgia Treatment Market
10.2.6.6.1 Rest of Europe Neuralgia Treatment Market by Treatment Type
10.2.6.6.2 Rest of Europe Neuralgia Treatment Market by Indication
10.2.6.6.3 Rest of Europe Neuralgia Treatment Market by Distribution channels
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Neuralgia Treatment Market Overview
10.3.2 Asia-Pacific Neuralgia Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Neuralgia Treatment Market Forecasts and Analysis - By Treatment Type
10.3.4 Asia-Pacific Neuralgia Treatment Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Neuralgia Treatment Market Forecasts and Analysis - By Distribution channels
10.3.6 Asia-Pacific Neuralgia Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Neuralgia Treatment Market
10.3.6.1.1 Australia Neuralgia Treatment Market by Treatment Type
10.3.6.1.2 Australia Neuralgia Treatment Market by Indication
10.3.6.1.3 Australia Neuralgia Treatment Market by Distribution channels
10.3.6.2 China Neuralgia Treatment Market
10.3.6.2.1 China Neuralgia Treatment Market by Treatment Type
10.3.6.2.2 China Neuralgia Treatment Market by Indication
10.3.6.2.3 China Neuralgia Treatment Market by Distribution channels
10.3.6.3 India Neuralgia Treatment Market
10.3.6.3.1 India Neuralgia Treatment Market by Treatment Type
10.3.6.3.2 India Neuralgia Treatment Market by Indication
10.3.6.3.3 India Neuralgia Treatment Market by Distribution channels
10.3.6.4 Japan Neuralgia Treatment Market
10.3.6.4.1 Japan Neuralgia Treatment Market by Treatment Type
10.3.6.4.2 Japan Neuralgia Treatment Market by Indication
10.3.6.4.3 Japan Neuralgia Treatment Market by Distribution channels
10.3.6.5 South Korea Neuralgia Treatment Market
10.3.6.5.1 South Korea Neuralgia Treatment Market by Treatment Type
10.3.6.5.2 South Korea Neuralgia Treatment Market by Indication
10.3.6.5.3 South Korea Neuralgia Treatment Market by Distribution channels
10.3.6.6 Rest of Asia-Pacific Neuralgia Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Neuralgia Treatment Market by Treatment Type
10.3.6.6.2 Rest of Asia-Pacific Neuralgia Treatment Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Neuralgia Treatment Market by Distribution channels
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Neuralgia Treatment Market Overview
10.4.2 Middle East and Africa Neuralgia Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Neuralgia Treatment Market Forecasts and Analysis - By Treatment Type
10.4.4 Middle East and Africa Neuralgia Treatment Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Neuralgia Treatment Market Forecasts and Analysis - By Distribution channels
10.4.6 Middle East and Africa Neuralgia Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Neuralgia Treatment Market
10.4.6.1.1 South Africa Neuralgia Treatment Market by Treatment Type
10.4.6.1.2 South Africa Neuralgia Treatment Market by Indication
10.4.6.1.3 South Africa Neuralgia Treatment Market by Distribution channels
10.4.6.2 Saudi Arabia Neuralgia Treatment Market
10.4.6.2.1 Saudi Arabia Neuralgia Treatment Market by Treatment Type
10.4.6.2.2 Saudi Arabia Neuralgia Treatment Market by Indication
10.4.6.2.3 Saudi Arabia Neuralgia Treatment Market by Distribution channels
10.4.6.3 U.A.E Neuralgia Treatment Market
10.4.6.3.1 U.A.E Neuralgia Treatment Market by Treatment Type
10.4.6.3.2 U.A.E Neuralgia Treatment Market by Indication
10.4.6.3.3 U.A.E Neuralgia Treatment Market by Distribution channels
10.4.6.4 Rest of Middle East and Africa Neuralgia Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Neuralgia Treatment Market by Treatment Type
10.4.6.4.2 Rest of Middle East and Africa Neuralgia Treatment Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Neuralgia Treatment Market by Distribution channels
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Neuralgia Treatment Market Overview
10.5.2 South and Central America Neuralgia Treatment Market Forecasts and Analysis
10.5.3 South and Central America Neuralgia Treatment Market Forecasts and Analysis - By Treatment Type
10.5.4 South and Central America Neuralgia Treatment Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Neuralgia Treatment Market Forecasts and Analysis - By Distribution channels
10.5.6 South and Central America Neuralgia Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Neuralgia Treatment Market
10.5.6.1.1 Brazil Neuralgia Treatment Market by Treatment Type
10.5.6.1.2 Brazil Neuralgia Treatment Market by Indication
10.5.6.1.3 Brazil Neuralgia Treatment Market by Distribution channels
10.5.6.2 Argentina Neuralgia Treatment Market
10.5.6.2.1 Argentina Neuralgia Treatment Market by Treatment Type
10.5.6.2.2 Argentina Neuralgia Treatment Market by Indication
10.5.6.2.3 Argentina Neuralgia Treatment Market by Distribution channels
10.5.6.3 Rest of South and Central America Neuralgia Treatment Market
10.5.6.3.1 Rest of South and Central America Neuralgia Treatment Market by Treatment Type
10.5.6.3.2 Rest of South and Central America Neuralgia Treatment Market by Indication
10.5.6.3.3 Rest of South and Central America Neuralgia Treatment Market by Distribution channels
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NEURALGIA TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. NEURALGIA TREATMENT MARKET, KEY COMPANY PROFILES
13.1. BIOGEN INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CADILA HEALTHCARE LIMITED
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. TEVA PHARMACEUTICALS LTD.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLENMARK PHARMS LTD.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVARTIS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JANSSEN PHARMACEUTICALS, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. JOHNSON AND JOHNSON SERVICES, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PFIZER INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Biogen Inc.
2. Cadila Healthcare Limited
3. Teva Pharmaceuticals Ltd.
4. GlaxoSmithKline PLC
5. GLENMARK PHARMS LTD.
6. Novartis AG
7. Janssen Pharmaceuticals, Inc.
8. Johnson & Johnson Services, Inc.
9. Takeda Pharmaceutical Company Limited
10. Pfizer Inc.
TIPRE00015977
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking